Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Major trial launched to explore GLP-1 benefit in dementia A large-scale trial has been launched, with $100 million in backing, to explore whether lifestyle changes coupled with GLP-1 agonists or similar incretin therapies can reduce the risk of dementia
Role of glutathione in cellular resistance to alkylating agents
Bioidentical hormones, red light therapy, uniquely-formulated IV therapies and other treatment options are also available as necessary for each individual's needs
B.PurupS
US$ 23.02
US$ 22.44
US$ 28.02
